Alto Neuroscience Inc.

ANRONYSE • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
27.54 USD
↗ 0.21 (0.77%)AT CLOSE (11:59 AM EDT)
27.53
↘ 0.01 (0.04%)
POST MARKET (AS OF 07:26 PM EDT)
Post Market
AS OF 07:26 PM EDT
27.53
↘ 0.01 (0.04%)
🔴Market: CLOSED

Alto Neuroscience Inc. (ANRO) trades at $27.13 per share. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place ANRO at a fair price relative to peers.

Technical & fundamental data as of Jul 17, 2026.

Open?$26.63
High?$28.82
Low?$26.44
Prev. Close?$27.33
Volume?777.4K
Avg. Volume?645.6K
VWAP?$27.96
Rel. Volume?1.20x
Bid / Ask
Bid?$26.65 × 100
Ask?$29.50 × 400
Spread?$2.85
Midpoint?$28.08
Valuation & Ratios
Market Cap?1.1B
Shares Out?35.1M
Float?25.3M
Float %?72.0%
P/E Ratio?N/A
P/B Ratio?4.37
EPS?-$1.91
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Themes
Biotech - Drug Development›Neuroscience & CNSHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
68
Market Cap
1.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.altoneuroscience.com
Listed
2024-02-02
Address
650 CASTRO STREET, SUITE 450
MOUNTAIN VIEW, CA 94041
Phone: 773-255-5012
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
36
Piotroski F-Score?0/9Weak
Altman Z-Score?18.41Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?9.54%Elevated
Short Interest?2.4M
Days to Cover?3.0
Free Float25.3M
Avg Daily Volume805.5K
Settlement Date2026-06-30
Financial Health
Current Ratio?20.52Strong
Quick Ratio?20.52Strong
Cash Ratio?20.11Strong
Debt/Equity?0.08Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
41
4.37FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-10.6CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
6
-30.5%WEAK▾
ROA?
S&P
3
-26.9%WEAK▾
Cash Flow & Enterprise
FCF?$-62860000
Enterprise Value?$816.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist